menu
    • menu

    Company profile for Kaken Pharmaceuticals

    NEW Drugs in Dev: 3
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The origin of KAKEN PHARMACEUTICAL Co., Ltd., can be traced back to the Institute of Physical and Chemical Research ( Riken ), established in 1917. The Company started pharmaceutical business with full-scale development of penicillin and streptomycin based on Riken's own technologies in 1948. 　The new headquarters were opened in 1998 in Bunkyo Green Court, an urban community center in Tokyo, Japan, where KAKEN's origin, Rik...
    The origin of KAKEN PHARMACEUTICAL Co., Ltd., can be traced back to the Institute of Physical and Chemical Research ( Riken ), established in 1917. The Company started pharmaceutical business with full-scale development of penicillin and streptomycin based on Riken's own technologies in 1948. 　The new headquarters were opened in 1998 in Bunkyo Green Court, an urban community center in Tokyo, Japan, where KAKEN's origin, Riken, started. 　KAKEN's ongoing quest is to bring smiles and happiness to as many people as possible. For this purpose, the Company strives to improve the quality of life of patients through the development and distribution of superior drugs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kaken Pharmaceuticalsjapan Flag
    Country
    Country
    Japan
    Address
    Address
    20th Floor, Bunkyo Green Court
    Telephone
    Telephone
    +81-3-5977-5002
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.kaken.co.jp/english/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kaken Strengthens Late-Stage HAE Portfolio with $32 M Astria Deal
    Kaken Strengthens Late-Stage HAE Portfolio with $32 M Astria Deal

    09 Aug 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/kaken-strengthens-late-stage-hae-portfolio-32m-japanese-deal-astrias-navenibart

    FIERCE BIOTECH
    09 Aug 2025
    Share Share
    KalVista sells Japanese rights for HAE drug to Kaken
    KalVista sells Japanese rights for HAE drug to Kaken

    08 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250408053048/en/KalVista-Pharmaceuticals-Enters-Into-Licensing-Agreement-With-Kaken-Pharmaceutical-to-Commercialize-Sebetralstat-for-HAE-in-Japan

    BUSINESSWIRE
    08 Apr 2025
    Share Share
    Whitehawk Completes Sale of Aadi Subsidiary to Kaken Pharma
    Whitehawk Completes Sale of Aadi Subsidiary to Kaken Pharma

    26 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/whitehawk-therapeutics-completes-strategic-transformation-with-successful-closing-of-sale-of-aadi-subsidiary-to-kaken-pharmaceuticals-302411424.html

    PR NEWSWIRE
    26 Mar 2025
    Share Share
    Alumis and Kaken Pharma Collaborate on ESK-001 in Japan
    Alumis and Kaken Pharma Collaborate on ESK-001 in Japan

    25 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/25/3048418/0/en/Alumis-and-Kaken-Pharmaceutical-Announce-Collaboration-and-Licensing-Agreement-for-ESK-001-in-Dermatology-in-Japan.html

    GLOBENEWSWIRE
    25 Mar 2025
    Share Share
    Kaken, J&J ink potential $1.2B-plus STAT6 deal
    Kaken, J&J ink potential $1.2B-plus STAT6 deal

    28 Dec 2024

    // PRESS RELEASE

    https://www.jnj.com/media-center/press-releases/johnson-johnson-to-license-novel-oral-assets-further-strengthening-commitment-to-atopic-dermatitis

    PRESS RELEASE
    28 Dec 2024
    Share Share
    bitBiome and Kaken sign agreement on discovery of drugs for infectious diseases
    bitBiome and Kaken sign agreement on discovery of drugs for infectious diseases

    29 Mar 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/bitbiome-and-kaken-pharmaceuticals-sign-joint-research-agreement-on-the-discovery-of-drugs-for-infectious-diseases-301781763.html

    PR NEWSWIRE
    29 Mar 2023
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Kaken Pharmaceuticals and get a quotation

    Kaken Pharmaceuticals is a supplier offers 12 products (APIs, Excipients or Intermediates).

    Find Butenafine Hydrochloride bulk with DMF, JDMF offered by Kaken Pharmaceuticals

    Find Dofetilide bulk with DMF offered by Kaken Pharmaceuticals

    Find Efinaconazole bulk with DMF offered by Kaken Pharmaceuticals

    Find Sofpironium Bromide bulk with DMF offered by Kaken Pharmaceuticals

    Find Tolazamide bulk with JDMF offered by Kaken Pharmaceuticals

    Find Medium / medium additive · bFGF Solution, MF bulk with JDMF offered by Kaken Pharmaceuticals

    Find Colistin Sulfate bulk offered by Kaken Pharmaceuticals

    Find Efinaconazole bulk offered by Kaken Pharmaceuticals

    Find Pralmorelin bulk offered by Kaken Pharmaceuticals

    Find KP-413 DRUG SUBMSTANCE bulk offered by Kaken Pharmaceuticals

    Find MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN SHIZUOKA PREFECTURE, JAPAN. bulk offered by Kaken Pharmaceuticals

    Find Salinomycin bulk offered by Kaken Pharmaceuticals

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search